FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Axel Zander

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Nicolaus Kröger; M Kropff; K-H Pflüger; Georgia Schilling; T Stübig; Christine Wolschke; Tatjana Zabelina; Djordje Atanackovic; Francis Ayuk; Anthony Oyekunle; A Badbaran; A Burchert; T Hansen; Y Hildebrandt; Evgeny Klyuchnikov; Axel R Zander
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Axel Zander (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anthony Oyekunle; Philippe Schafhausen; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Axel R Zander; Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Mascha Binder; Maximilian Christopeit; Heinrich Lellek; Ingo Müller; Nicolaus Kröger
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Annals of hematology 2013;92(4):487-96.
2013: Nicolaus Kröger; Georgia Schilling; Sabine Schwarz; Thomas Stübig; Christine Wolschke; Tatjana Zabelina; Silke Zeschke; Haefaa Alchalby; Djordje Atanackovic; Francis Ayuk; Ulrike Bacher; A Badbaran; Boris Fehse; Timon Hansen; Marion Heinzelmann; Evgeny Klyuchnikov; Axel R Zander
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):398-404.
2013: Nicolaus Kröger; M Kropff; K-H Pflüger; Georgia Schilling; T Stübig; Christine Wolschke; Tatjana Zabelina; Djordje Atanackovic; Francis Ayuk; Anthony Oyekunle; A Badbaran; A Burchert; T Hansen; Y Hildebrandt; Evgeny Klyuchnikov; Axel R Zander
Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients.
Bone marrow transplantation 2013;48(3):403-7.
2012: Evgeny Klyuchnikov; Guido Kobbe; Christian Könecke; Arnon Nagler; Avichai Shimoni; Christine Wolschke; Axel R Zander; Ulrike Bacher; Martin Bornhäuser; Ernst Holler; Nicolaus Kröger
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
British journal of haematology 2012;159(2):172-81.
2012: Djordje Atanackovic; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; York Hildebrandt; Christiane Keller; Nesrine Lajmi; Andreas H Marx; Sabrina Meyer; Jens Panse; Henrike Reinhard; Orhan Sezer; Julia Templin; Ria Uhlig; Axel R Zander; Jozef Zustin; Nicolaus Kröger
Role of interleukin 16 in multiple myeloma.
Journal of the National Cancer Institute 2012;104(13):1005-20.
2012: Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Wolfgang Bethge; Martin Bornhäuser; Guntram Büsche; Ernst Holler; Guido Kobbe; Hans Michael Kvasnicka; Rainer Schwerdtfeger; Dinah-Rohina Yunus; Tatjana Zabelina; Axel R Zander; Nicolaus Kröger
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.
British journal of haematology 2012;157(1):75-85.
2011: Claudia Langebrake; Michael Baehr; Friederike Bernhardt; Nicolaus Kröger; Axel R Zander
Drug dosing and monitoring in obese patients undergoing allogenic stem cell transplantation.
International journal of clinical pharmacy 2011;33(6):918-24.
2011: Djordje Atanackovic; Katrin Bartels; Carsten Bokemeyer; Yanran Cao; York Hildebrandt; Adam Jadczak; Sebastian Kobold; Nesrine Lajmi; Andreas H Marx; Sabrina Meyer; Jens Panse; Henrike Reinhard; Julia Templin; Axel R Zander; Nicolaus Kröger
Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.
Haematologica 2011;96(10):1512-20.
2011: Anthony Oyekunle; Axel R Zander; Michele Baccarani; Evgeny Klyuchnikov; Nicolaus Kröger; S Ocheni; Ulrike Bacher
Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors.
Acta haematologica 2011;126(1):30-9.
2011: Claudia Lange; Bärbel Brunswig-Spickenheier; Heike Cappallo-Obermann; Katharina Eggert; Ursula M Gehling; Cornelia Rudolph; Brigitte Schlegelberger; Kerstin Cornils; Jozef Zustin; Andrej-Nikolai Spiess; Axel R Zander
Radiation rescue: mesenchymal stromal cells protect from lethal irradiation.
PloS one 2011;6(1):e14486.
2011: Heinrich Lellek; Dirk Waldenmaier; Joachim Dahlke; Francis Ayuk; Christine Wolschke; Nicolaus Kröger; Axel R Zander
Caspofungin plus posaconazole as salvage therapy of invasive fungal infections in immunocompromised patients.
Mycoses 2011;54 Suppl 1():39-44.
2010: Bettina Wiedemann; Evgeny Klyuchnikov; Nicolaus Kröger; Tatjana Zabelina; Tanja Stahl; Silke Zeschke; A Badbaran; Francis Ayuk; Haefaa Alchalby; Christine Wolschke; Carsten Bokemeyer; Boris Fehse; Axel R Zander; Ulrike Bacher
Chimerism studies with quantitative real-time PCR in stem cell recipients with acute myeloid leukemia.
Experimental hematology 2010;38(12):1261-71.
2010: Haefaa Alchalby; A Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.
Blood 2010;116(18):3572-81.
2010: Tanja Stahl; A Badbaran; Nicolaus Kröger; Evgeny Klyuchnikov; Tatjana Zabelina; Silke Zeschke; Philippe Schafhausen; Waltraud Schultz; Svetlana Asenova; Anna Smirnova; Christine Wolschke; Francis Ayuk; Axel R Zander; Boris Fehse; Ulrike Bacher
Minimal residual disease diagnostics in patients with acute myeloid leukemia in the post-transplant period: comparison of peripheral blood and bone marrow analysis.
Leukemia & lymphoma 2010;51(10):1837-43.
2010: Yanran Cao; Tim Luetkens; Sebastian Kobold; York Hildebrandt; Maja Gordic; Nesrine Lajmi; Sabrina Meyer; Katrin Bartels; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger; Djordje Atanackovic
The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients.
Experimental hematology 2010;38(10):860-7.
2010: H Alchalby; A Badbaran; O Bock; Boris Fehse; Ulrike Bacher; Axel R Zander; Nicolaus Kröger
Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT.
Bone marrow transplantation 2010;45(9):1404-7.
2010: Irene Cavattoni; Francis Ayuk; Axel R Zander; Tatjana Zabelina; Adelbert Bacher; Erdogan Cayroglu; Volker Knospe; Till Illies; Martin Aepfelbacher; Gisbert Richard; Nicolaus Kröger; Ulrike Bacher
Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny.
Leukemia & lymphoma 2010;51(8):1530-5.
2010: Evgeny Klyuchnikov; Svetlana Asenova; Wolfgang Kern; Gökhan Kilinc; Francis Ayuk; Bettina Wiedemann; Michael V Lioznov; Petra Freiberger; Yuriy Zalyalov; Axel R Zander; Nicolaus Kröger; Ulrike Bacher
Post-transplant immune reconstitution after unrelated allogeneic stem cell transplant in patients with acute myeloid leukemia.
Leukemia & lymphoma 2010;51(8):1450-63.
2010: Bärbel Brunswig-Spickenheier; Janna Boche; Christof Westenfelder; Frauke Peimann; Achim D Gruber; Kai Jaquet; Korff Krause; Jozef Zustin; Axel R Zander; Claudia Lange
Limited immune-modulating activity of porcine mesenchymal stromal cells abolishes their protective efficacy in acute kidney injury.
Stem cells and development 2010;19(5):719-29.
2010: Djordje Atanackovic; York Hildebrandt; Adam Jadczak; Yanran Cao; Tim Luetkens; Sabrina Meyer; Sebastian Kobold; Katrin Bartels; Caroline Pabst; Nesrine Lajmi; Maja Gordic; Tanja Stahl; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells.
Haematologica 2010;95(5):785-93.
2010: Michael V Lioznov; J El-Cheikh; F Hoffmann; Y Hildebrandt; Francis Ayuk; Christine Wolschke; Djordje Atanackovic; Georgia Schilling; A Badbaran; Ulrike Bacher; Boris Fehse; Axel R Zander; D Blaise; M Mohty; Nicolaus Kröger
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44(+)) and T (HLA-DR(+)) cells.
Bone marrow transplantation 2010;45(2):349-53.
2010: Nicolaus Kröger; Avichai Shimoni; Georgia Schilling; Rainer Schwerdtfeger; Martin Bornhäuser; Arnon Nagler; Axel R Zander; Marion Heinzelmann; Ronald Brand; Gösta Gahrton; Curly Morris; Dietger Niederwieser; Theo de Witte
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
British journal of haematology 2010;148(2):323-31.
2009: Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(26):5264-70.
2009: J Rischer; Angela Scherwath; Axel R Zander; Uwe Koch; Frank Schulz-Kindermann
Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation.
Bone marrow transplantation 2009;44(2):121-8.
2009: U Bacher; C Haferlach; S Schnittger; W Kern; N Kroeger; Axel R Zander; T Haferlach
Interactive diagnostics in the indication to allogeneic SCT in AML.
Bone marrow transplantation 2009;43(10):745-56.
2009: Sunday Ocheni; Gabriela B Iwanski; Philippe Schafhausen; Axel R Zander; Francis Ayuk; Evgeny Klyuchnikov; Tatjana Zabelina; Walter Fiedler; Susanne Schnittger; Andreas Hochhaus; Tim H Brümmendorf; Nicolaus Kröger; Ulrike Bacher
Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.
Leukemia & lymphoma 2009;50(4):551-8.
2009: Djordje Atanackovic; Tim Luetkens; York Hildebrandt; Julia Arfsten; Katrin Bartels; Christiane Horn; Tanja Stahl; Yanran Cao; Axel R Zander; Carsten Bokemeyer; Nicolaus Kröger
Longitudinal analysis and prognostic effect of cancer-testis antigen expression in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(4):1343-52.
2009: Philippe Schafhausen; Judith Dierlamm; Carsten Bokemeyer; Tim H Bruemmendorf; Ulrike Bacher; Axel R Zander; Susanne Schnittger; Andreas Hochhaus
Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.
Cancer genetics and cytogenetics 2009;189(1):63-7.
2009: Evgeny Klyuchnikov; Philippe Schafhausen; Nicolaus Kröger; Tim H Brummendorf; Okay Osanmaz; Svetlana Asenova; Tatjana Zabelina; Sunday Ocheni; Francis Ayuk; Axel R Zander; Ulrike Bacher
Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.
Acta haematologica 2009;122(1):6-10.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Christine Wolschke; Boris Fehse; Ulrike Bacher; Rudolf Erttmann; Nicolaus Kröger; Axel R Zander
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(8):913-9.
2008: Ulrike Bacher; Axel R Zander; Torsten Haferlach; Susanne Schnittger; Boris Fehse; Nicolaus Kröger
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.
Bone marrow transplantation 2008;42(3):145-57.
2008: Francis Ayuk; Galina Diyachenko; Tatjana Zabelina; Jens Panse; Christine Wolschke; Thomas Eiermann; Thomas Binder; Boris Fehse; Rudolf Erttmann; Hartmut Kabisch; Ulrike Bacher; Nicolaus Kröger; Axel R Zander
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
Experimental hematology 2008;36(8):1047-54.
2008: Francis Ayuk; Nabil Atassi; Gunther Schuch; Sormeh Mina; Lubin Fang; Carsten Bokemeyer; Boris Fehse; Axel R Zander; Nicolaus Kröger
Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.
Leukemia research 2008;32(8):1200-6.
2008: Axel R Zander; C Schmoor; Nicolaus Kröger; W Krüger; Volker Möbus; Norbert Frickhofen; Bernd Metzner; Wolfgang E Berdel; M Koenigsmann; E Thiel; Hannes Wandt; K Possinger; R Kreienberg; Martin Schumacher; W Jonat
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1082-9.
2008: Michael V Lioznov; A Badbaran; Boris Fehse; Ulrike Bacher; Axel R Zander; N M Kröger
Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.
Bone marrow transplantation 2008;41(10):913-6.
2008: Djordje Atanackovic; Yanran Cao; Tim Luetkens; Jens Panse; Christiane Faltz; Julia Arfsten; Katrin Bartels; Christine Wolschke; Thomas Eiermann; Axel R Zander; Boris Fehse; Carsten Bokemeyer; Nicolaus Kroger
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Haematologica 2008;93(3):423-30.
2007: Eray Goekkurt; Jan Stoehlmacher; Christian Stueber; Christine Wolschke; Thomas Eiermann; Simona Iacobelli; Axel R Zander; Gerhard Ehninger; Nicolaus Kröger
Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.
Anticancer research 2007;27(6C):4377-80.
2007: Claudia Lange; Figen Cakiroglu; Andrej-Nikolai Spiess; Heike Cappallo-Obermann; Judith Dierlamm; Axel R Zander
Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
Journal of cellular physiology 2007;213(1):18-26.
2007: Harald Ittrich; Claudia Lange; Florian Tögel; Axel R Zander; Hannes Dahnke; Christof Westenfelder; Gerhard Adam; Claus Nolte-Ernsting
In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T.
Journal of magnetic resonance imaging : JMRI 2007;25(6):1179-91.
2007: Frank Schulz-Kindermann; Anja Mehnert; Angela Scherwath; Lena Schirmer; Barbara Schleimer; Axel R Zander; Uwe Koch
Cognitive function in the acute course of allogeneic hematopoietic stem cell transplantation for hematological malignancies.
Bone marrow transplantation 2007;39(12):789-99.
2007: Anja Mehnert; Angela Scherwath; Lena Schirmer; Barbara Schleimer; Corinna Petersen; Frank Schulz-Kindermann; Axel R Zander; Uwe Koch
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
Patient education and counseling 2007;66(1):108-18.
2007: Ulrike Mösbauer; Francis Ayuk; Heike Schieder; Michael V Lioznov; Axel R Zander; Nicolaus Kröger
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.
Haematologica 2007;92(2):275-6.
2007: Djordje Atanackovic; Julia Arfsten; Yanran Cao; Sacha Gnjatic; Frank Schnieders; Katrin Bartels; Georgia Schilling; Christiane Faltz; Christine Wolschke; Judith Dierlamm; Gerd Ritter; Thomas Eiermann; Dieter K Hossfeld; Axel R Zander; Achim A Jungbluth; Lloyd J Old; Carsten Bokemeyer; Nicolaus Kröger
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation.
Blood 2007;109(3):1103-12.
2007: Nicolaus Kröger; Anita Badbaran; Ernst Holler; Joachim Hahn; Guido Kobbe; Martin Bornhäuser; Andreas Reiter; Tatjana Zabelina; Axel R Zander; Boris Fehse
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.
Blood 2007;109(3):1316-21.
2006: Lubin Fang; Claudia Lange; Melanie Engel; Axel R Zander; Boris Fehse
Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation.
Transplantation 2006;82(10):1370-3.
2006: Nicolaus Kröger; Markus Frick; Oleg Gluz; Svjetlana Mohrmann; Bernd Metzner; Christian Jackisch; Yon Ko; Hans-Walter Lindemann; Carl Richard Meier; Hans Peter Lohrmann; Ute Ruffert; Mathias Hänel; Heinrich Bodenstein; Andreas Neubauer; Gerhard Ehninger; Hans-Heinrich Wolf; Kathrin Kolbe; Karin Burock; Axel R Zander; Ulrike Nitz
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(24):3919-26.
2006: Claudia Lange; Helge Bruns; Dietrich Kluth; Axel R Zander; Henning C Fiegel
Hepatocytic differentiation of mesenchymal stem cells in cocultures with fetal liver cells.
World journal of gastroenterology : WJG 2006;12(15):2394-7.
2006: Angela Scherwath; Anja Mehnert; Barbara Schleimer; Lena Schirmer; Fabian Fehlauer; R Kreienberg; B Metzner; E Thiel; Axel R Zander; Frank Schulz-Kindermann; Uwe Koch
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(3):415-23.
2006: Ulrika M Schade; Nina Nehmann; Hans-Peter Horny; Peter Prehm; Bertrand Delpech; William H Krüger; Axel R Zander; Udo Schumacher
Hyaluronate and its receptors in bone marrow.
Acta histochemica 2006;108(2):141-7.
2006: Martin Bornhäuser; Nicolaus Kröger; Rainer Schwerdtfeger; Karin Schafer-Eckart; Herbert G Sayer; Christoph Scheid; Matthias Stelljes; Joachim Kienast; Peter Mundhenk; Stefan Fruehauf; Michael Kiehl; Hannes Wandt; Catrin Theuser; Gerhard Ehninger; Axel R Zander
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
European journal of haematology 2006;76(1):9-17.
2006: Joachim Dahlke; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Natalja Fehse; Christine Wolschke; Olga Waschke; Heike Schieder; Helmut Renges; William H Krüger; A Kruell; Axel Hinke; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.
Bone marrow transplantation 2006;37(2):155-63.
2006: Anthony Oyekunle; Nicolaus Kröger; Tatjana Zabelina; Francis Ayuk; Heike Schieder; Helmut Renges; Natalja Fehse; Olga Waschke; Boris Fehse; Hartmut Kabisch; Axel R Zander
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
Bone marrow transplantation 2006;37(1):45-50.
2005: Francis Ayuk; Lubin Fang; Boris Fehse; Axel R Zander; Nicolaus Kröger
Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells.
Experimental hematology 2005;33(12):1531-6.
2005: Claudia Lange; Florian Tögel; Harald Ittrich; Frederic Clayton; Claus Nolte-Ernsting; Axel R Zander; Christof Westenfelder
Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.
Kidney international 2005;68(4):1613-7.
2005: Claudia Lange; Philipp Bassler; Michael V Lioznov; Helge Bruns; Dietrich Kluth; Axel R Zander; Henning C Fiegel
Liver-specific gene expression in mesenchymal stem cells is induced by liver cells.
World journal of gastroenterology : WJG 2005;11(29):4497-504.
2005: Harald Ittrich; Claudia Lange; Hannes Dahnke; Axel R Zander; Gerhard Adam; Claus Nolte-Ernsting
[Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T].
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin 2005;177(8):1151-63.
2005: Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl S Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel R Zander; David I Marks
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
2005: Michael V Lioznov; P Freiberger; Nicolaus Kröger; Axel R Zander; Boris Fehse
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.
Bone marrow transplantation 2005;35(9):909-14.
2005: Claudia Lange; Jens Schroeder; Norbert Stute; Michael V Lioznov; Axel R Zander
High-potential human mesenchymal stem cells.
Stem cells and development 2005;14(1):70-80.
2005: Axel R Zander; Nicolaus Kroger
High-dose therapy for breast cancer - a case of suspended animation.
Acta haematologica 2005;114(4):248-54.
2005: Claudia Lange; P Bassler; Michael V Lioznov; Helge Bruns; Dietrich Kluth; Axel R Zander; Henning C Fiegel
Hepatocytic gene expression in cultured rat mesenchymal stem cells.
Transplantation proceedings 2005;37(1):276-9.
2005: William H Krüger; Bettina Rüssmann; Maike de Wit; Nicolaus Kröger; Helmut Renges; Ingo Sobottka; Axel R Zander
Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.
Acta haematologica 2005;113(2):104-8.
2004: Norbert Stute; Katja Holtz; Michael Bubenheim; Claudia Lange; Felix Blake; Axel R Zander
Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
Experimental hematology 2004;32(12):1212-25.
2004: Holger Rohde; Matthias Kalitzky; Nicolaus Kröger; Stefanie Scherpe; Matthias A Horstkotte; Johannes K-M Knobloch; Axel R Zander; Dietrich Mack
Detection of virulence-associated genes not useful for discriminating between invasive and commensal Staphylococcus epidermidis strains from a bone marrow transplant unit.
Journal of clinical microbiology 2004;42(12):5614-9.
2004: Boris Fehse; Francis Ayuk; Nicolaus Kröger; Lubin Fang; Klaus Kühlcke; Marion Heinzelmann; Tatjana Zabelina; Axel A Fauser; Axel R Zander
Evidence for increased risk of secondary graft failure after in vivo depletion of suicide gene-modified T lymphocytes transplanted in conjunction with CD34+-enriched blood stem cells.
Blood 2004;104(10):3408-9.
2004: Nicolaus Kröger; Avichai Shimoni; Maria Zagrivnaja; Francis Ayuk; Michael V Lioznov; Heike Schieder; Helmut Renges; Boris Fehse; Tatjana Zabelina; Arnon Nagler; Axel R Zander
Low-dose thalidomide and donor lymphocyte infusion as adoptive immunotherapy after allogeneic stem cell transplantation in patients with multiple myeloma.
Blood 2004;104(10):3361-3.
2004: Nicolaus Kröger; Jose A Perez-Simon; Han Myint; Hans Klingemann; Avichai Shimoni; Arnon Nagler; Rodrigo Martino; Adrian Alegre; Jose F Tomas; Rainer Schwerdtfeger; Michael Kiehl; Axel A Fauser; Herbert G Sayer; Angel Leon; Jörg Beyer; Tatjana Zabelina; Francis Ayuk; Jesús F San Miguel; Ronald Brand; Axel R Zander
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(10):698-708.
2004: Michael Kiehl; Ludwig Kraut; Rainer Schwerdtfeger; Bernd Hertenstein; Mats Remberger; Nicolaus Kroeger; Mathias Stelljes; Martin Bornhaeuser; Hans Martin; Christoph Scheid; Arnold Ganser; Axel R Zander; Joachim Kienast; Gerhard Ehninger; Dieter Hoelzer; Volker Diehl; Axel A Fauser; Olle Ringden
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2816-25.
2004: Axel R Zander; Nicolaus Kröger; C Schmoor; William H Krüger; Volker Möbus; Norbert Frickhofen; Bernd Metzner; W Schultze; Wolfgang E Berdel; M Koenigsmann; E Thiel; Hannes Wandt; K Possinger; Lorenz Trümper; R Kreienberg; Marion Carstensen; E H Schmidt; Fritz Jänicke; M Schumacher; Walter Jonat
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2273-83.
2004: Sonja Loges; Boris Fehse; Marc A Brockmann; Katrin Lamszus; Martin Butzal; Markus Guckenbiehl; Gunter Schuch; Süleyman Ergün; Uta Fischer; Axel R Zander; Dieter K Hossfeld; Walter Fiedler; Ursula M Gehling
Identification of the adult human hemangioblast.
Stem cells and development 2004;13(3):229-42.
2004: Nicolaus Kröger; Georgia Schilling; Hermann Einsele; Peter Liebisch; Avichai Shimoni; Arnon Nagler; Jose A Perez-Simon; Jesús F San Miguel; Michael Kiehl; Axel A Fauser; Rainer Schwerdtfeger; Hannes Wandt; Herbert G Sayer; Han Myint; Hans Klingemann; Tatjana Zabelina; Judith Dierlamm; Axel Hinke; Axel R Zander
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.
Blood 2004;103(11):4056-61.
2004: Nicolaus Kröger; Stefan Sonnenberg; Lourdes Cortes-Dericks; Petra Freiberger; Hanke Mollnau; Axel R Zander
Kinetics of G-CSF and CD34+ cell mobilization after once or twice daily stimulation with rHu granulocyte-stimulating factor (lenograstim) in healthy volunteers: an intraindividual crossover study.
Transfusion 2004;44(1):104-10.
2003: Nicolaus Kröger; L Damon; Axel R Zander; Hannes Wandt; Günter Derigs; P Ferrante; Taner Demirer; G Rosti
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Bone marrow transplantation 2003;32(12):1153-7.
2003: Olga S Kustikova; Anke Wahlers; Klaus Kuhlcke; Birgit Stahle; Axel R Zander; Christopher Baum; Boris Fehse
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population.
Blood 2003;102(12):3934-7.
2003: Hermann Einsele; M Bamberg; W Budach; H Schmidberger; C F Hess; B Wörmann; Christoph Meisner; Christian Straka; Holger Hebart; Lorenz Trümper; Nicolaus Kröger; Axel R Zander; Susanna Hegewisch-Becker; D K Hossfeld; H Schmidt; P Müller; Günter Schlimok; Bernd Hertenstein; D Peest; Bernd Metzner; Norbert Frickhofen; Lothar Kanz; W I Bensinger
A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma.
Bone marrow transplantation 2003;32(6):593-9.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Johannes Schetelig; Christian Thiede; Martin Bornhauser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Herbert G Sayer; N Kroger; M Hensel; christian scheffold; Thomas K Held; K Hoffken; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2747-53.
2003: William H Krüger; Bernhard Zöllner; Paul-Michael Kaulfers; Axel R Zander
Effective protection of allogeneic stem cell recipients against Aspergillosis by HEPA air filtration during a period of construction--a prospective survey.
Journal of hematotherapy & stem cell research 2003;12(3):301-7.
2003: Nicolaus Kröger; Martin Bornhäuser; Gerhard Ehninger; Rainer Schwerdtfeger; H Biersack; Herbert G Sayer; Hannes Wandt; K Schäfer-Eckardt; Jörg Beyer; Michael Kiehl; Axel R Zander
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Annals of hematology 2003;82(6):336-42.
2003: Henning C Fiegel; Jantjeline Kluth; Michael V Lioznov; Stephanie Holzhüter; Boris Fehse; Axel R Zander; Dietrich Kluth
Hepatic lineages isolated from developing rat liver show different ways of maturation.
Biochemical and biophysical research communications 2003;305(1):46-53.
2003: M Weber; Nicolaus Kröger; Florian Langer; A Hansen; Tatjana Zabelina; Barbara Eifrig; Dieter K Hossfeld; Axel R Zander
Non-overt disseminated intravascular coagulation in patients during treatment with antithymocyte globulin for unrelated allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(9):817-22.
2003: Natalja Fehse; Boris Fehse; Nicolaus Kröger; Tatjana Zabelina; Petra Freiberger; William H Krüger; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantation.
Journal of hematotherapy & stem cell research 2003;12(2):237-42.
2003: Nicolaus Kröger; Axel R Zander; G Martinelli; P Ferrante; J M Moraleda; gian antonio da prada; Taner Demirer; Gerard Socie; G Rosti
Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):554-8.
2003: Henning C Fiegel; Michael V Lioznov; Lourdes Cortes-Dericks; Claudia Lange; Dietrich Kluth; Boris Fehse; Axel R Zander
Liver-specific gene expression in cultured human hematopoietic stem cells.
Stem cells (Dayton, Ohio) 2003;21(1):98-104.
2003: Henning C Fiegel; Jonas J h Park; Michael V Lioznov; Andreas Martin; Stefan Jaeschke-Melli; Peter M Kaufmann; Boris Fehse; Axel R Zander; Dietrich Kluth
Characterization of cell types during rat liver development.
Hepatology (Baltimore, Md.) 2003;37(1):148-54.
2002: Norbert Stute; Boris Fehse; Jens Schröder; Sönke Arps; Peter Adamietz; Karsten R Held; Axel R Zander
Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant.
Journal of hematotherapy & stem cell research 2002;11(6):977-84.
2002: Florian Tögel; Nicolaus Kröger; F Korioth; Boris Fehse; Axel R Zander
Molecular methods for detection and quantification of myeloma cells after bone marrow transplantation: comparison between real-time quantitative and nested PCR.
Journal of hematotherapy & stem cell research 2002;11(6):971-6.
2002: Jörg Hessling; Nicolaus Kröger; Mathias Werner; Tatjana Zabelina; Arne Hansen; Uwe Kordes; Francis Ayuk; Helmut Renges; Jens Panse; Rudolf Erttmann; Axel R Zander
Dose-reduced conditioning regimen followed by allogeneic stem cell transplantation in patients with myelofibrosis with myeloid metaplasia.
British journal of haematology 2002;119(3):769-72.
2002: Boris Fehse; Olga S Kustikova; Zhixiong Li; Anke Wahlers; Wolfgang Bohn; W R Beyer; D Chalmers; P Tiberghien; Klaus Kühlcke; Axel R Zander; Christopher Baum
A novel 'sort-suicide' fusion gene vector for T cell manipulation.
Gene therapy 2002;9(23):1633-8.
2002: Nicolaus Kröger; Herbert G Sayer; Rainer Schwerdtfeger; Michael Kiehl; Arnon Nagler; Helmut Renges; Tatjana Zabelina; Boris Fehse; Francis Ayuk; Georg Wittkowsky; Norbert Schmitz; Axel R Zander
Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality.
Blood 2002;100(12):3919-24.
2002: Nicolaus Kröger; Tatjana Zabelina; Helmut Renges; William H Krüger; Uwe Kordes; Johannes Rischewski; J Schrum; Martin Horstmann; Francis Ayuk; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
Annals of hematology 2002;81(11):627-31.
2002: Nicolaus Kröger; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Helmut Renges; Tatjana Zabelina; Boris Fehse; Florian Tögel; Georg Wittkowsky; Rolf Kuse; Axel R Zander
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma.
Blood 2002;100(3):755-60.
2002: Nicolaus Kröger; Axel R Zander
Dose and schedule effect of G-GSF for stem cell mobilization in healthy donors for allogeneic transplantation.
Leukemia & lymphoma 2002;43(7):1391-4.
2002: F Graf Finckenstein; Tatjana Zabelina; Matthias Dürken; Joachim Dahlke; Nicolaus Kröger; William H Krüger; Gritta E Janka-Schaub; Rudolf Erttmann; Axel R Zander; Hartmut Kabisch
[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
Klinische Pädiatrie 2002;214(4):206-11.
2002: Nicolaus Kröger; Tatjana Zabelina; Philippe Guardiola; Volker Runde; Jorge Sierra; Anja van Biezen; Dietger Niederwieser; Axel R Zander; Theo de Witte
Allogeneic stem cell transplantation of adult chronic myelomonocytic leukaemia. A report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
British journal of haematology 2002;118(1):67-73.
2002: Nicolaus Kröger; Helmut Renges; Stefan Sonnenberg; William H Krüger; Kai Gutensohn; T Dielschneider; Lourdes Cortes-Dericks; Axel R Zander
Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Bone marrow transplantation 2002;29(9):727-30.
2002: Alexander Carpinteiro; Stefan Peinert; Wolfram Ostertag; Axel R Zander; Dieter K Hossfeld; Klaus Kühlcke; Hans-Georg Eckert; Christopher Baum; Susanna Hegewisch-Becker
Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.
International journal of cancer. Journal international du cancer 2002;98(5):785-92.
2002: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Johannes Rischewski; Stefan Sonnenberg; Francis Ayuk; Florian Tögel; UM Schade; Henning C Fiegel; Rudolf Erttmann; C Löliger; Axel R Zander
In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors.
Bone marrow transplantation 2002;29(8):683-9.
2002: P G C Begemann; HT Hassan; Nicolaus Kröger; William H Krüger; Hartmut Kabisch; Axel R Zander
Correlation of time to platelet engraftment with amount of transplanted CD34+CD41+ cells after allogeneic bone marrow transplantation.
Journal of hematotherapy & stem cell research 2002;11(2):321-6.
2002: Klaus Kühlcke; Boris Fehse; Andrea Schilz; Sonja Loges; Carsten Lindemann; Francis Ayuk; Friederike Lehmann; Norbert Stute; Axel A Fauser; Axel R Zander; Hans-Georg Eckert
Highly efficient retroviral gene transfer based on centrifugation-mediated vector preloading of tissue culture vessels.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(4):473-8.
2002: Johannes Schetelig; Nicolaus Kröger; Thomas K Held; Christian Thiede; Andreas Krusch; Tatjana Zabelina; Marc Dubiel; Oliver Rick; Martin Bornhäuser; Gerhard Ehninger; Axel R Zander; Wolfgang Siegert
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Haematologica 2002;87(3):299-305.
2002: Mathias Hänel; Nicolaus Kröger; Stefan Sonnenberg; Martin Bornhäuser; William H Krüger; Frank Kroschinsky; Annette Hänel; Bernd Metzner; Josef Birkmann; B Schmid; MM Hoffknecht; Friedrich Fiedler; Gerhard Ehninger; Axel R Zander
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Annals of hematology 2002;81(2):96-102.
2002: Frank Schulz-Kindermann; U Hennings; G Ramm; Axel R Zander; Monika Hasenbring
The role of biomedical and psychosocial factors for the prediction of pain and distress in patients undergoing high-dose therapy and BMT/PBSCT.
Bone marrow transplantation 2002;29(4):341-51.
2002: Johannes Schetelig; Christian Thiede; Martin Bornhäuser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Nicolaus Kröger; M Hensel; christian scheffold; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 2002;81 Suppl 2():S47-8.
2001: William H Krüger; R J Hornung; B Hertenstein; W V Kern; Nicolaus Kröger; P Ljungman; Axel R Zander
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantation.
Journal of hematotherapy & stem cell research 2001;10(6):895-903.
2001: Nicolaus Kröger; Johannes Schetelig; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Wolfgang Siegert; Axel R Zander
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Bone marrow transplantation 2001;28(7):643-7.
2001: William H Krüger; Nicolaus Kröger; Florian Tögel; Helmut Renges; A Badbaran; R Hornung; R Jung; Kai Gutensohn; F Gieseking; Fritz Jänicke; Axel R Zander
Disseminated breast cancer cells prior to and after high-dose therapy.
Journal of hematotherapy & stem cell research 2001;10(5):681-9.
2001: Boris Fehse; A Chukhlovin; Klaus Kühlcke; O Marinetz; O Vorwig; Helmut Renges; William H Krüger; Tatjana Zabelina; O Dudina; F G Finckenstein; Nicolaus Kröger; Hartmut Kabisch; A Hochhaus; Axel R Zander
Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2001;10(3):419-25.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; J Schrum; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; P Schäfer; Axel Hinke; Axel R Zander
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulin.
British journal of haematology 2001;113(4):1060-71.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Matthias Dürken; F Graf von Finkenstein; Rudolf Erttmann; Hartmut Kabisch; Philippe Schafhausen; N Jaburg; C Löliger; Axel R Zander
Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors.
Annals of hematology 2001;80(4):209-15.
2001: William H Krüger; Nicolaus Kröger; Florian Tögel; A Badbaran; Helmut Renges; F Gieseking; Kai Gutensohn; Fritz Jänicke; Axel R Zander
Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells.
Journal of hematotherapy & stem cell research 2001;10(2):303-7.
2001: Nicolaus Kröger; Tatjana Zabelina; William H Krüger; Helmut Renges; Norbert Stute; Hartmut Kabisch; N Jaburg; C Löliger; Andreas Krüll; Axel R Zander
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
Bone marrow transplantation 2001;27(4):349-54.
2001: Florian Tögel; C Datta; A Badbaran; Nicolaus Kröger; Helmut Renges; F Gieseking; Fritz Jänicke; Axel R Zander; William H Krüger
Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells.
Journal of hematotherapy & stem cell research 2001;10(1):141-5.
2001: William H Krüger; R Jung; B Detlefsen; S Mumme; A Badbaran; J Brandner; Helmut Renges; Nicolaus Kröger; Axel R Zander
Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells.
Medical oncology (Northwood, London, England) 2001;18(1):33-8.
2001: Mathias Hänel; Nicolaus Kröger; Frank Kroschinsky; Josef Birkmann; Annette Hänel; R Herbst; Ralph Naumann; K Friedrichsen; Gerhard Ehninger; Axel R Zander; Friedrich Fiedler
Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
Journal of cancer research and clinical oncology 2001;127(6):387-95.
2000: W Krüger; C Datta; A Badbaran; Florian Tögel; Kai Gutensohn; I Carrero; Nicolaus Kröger; F Jänicke; Axel R Zander
Immunomagnetic tumor cell selection--implications for the detection of disseminated cancer cells.
Transfusion 2000;40(12):1489-93.
2000: Nicolaus Kröger; Helmut Renges; William H Krüger; Kai Gutensohn; C Löliger; I Carrero; L Cortes; Axel R Zander
A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
British journal of haematology 2000;111(3):761-5.
2000: Nicolaus Kröger; MM Hoffknecht; William H Krüger; W Zeller; Helmut Renges; Norbert Stute; R Zschaber; Axel R Zander
Allogeneic bone marrow transplantation for refractory mantle cell lymphoma.
Annals of hematology 2000;79(10):578-80.
2000: Nicolaus Kröger; Tatjana Zabelina; Stefan Sonnenberg; William H Krüger; Helmut Renges; Norbert Stute; F Finkenstein; U Mayer; K Holstein; Walter Fiedler; H Colberg; Ruth Sonnen; Rolf Kuse; Dietrich Braumann; Bernd Metzner; F del Valle; Rudolf Erttmann; Hartmut Kabisch; Axel R Zander
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Bone marrow transplantation 2000;26(7):711-6.
2000: Mathias Hänel; Nicolaus Kröger; MM Hoffknecht; S O Peters; Bernd Metzner; Friedrich Fiedler; Dietrich Braumann; J C Schubert; Hans-Jochen Illiger; Annette Hänel; William H Krüger; W Zeller; HJ Weh; Dieter K Hossfeld; Axel R Zander
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomas.
Annals of hematology 2000;79(6):304-11.
2000: Boris Fehse; O Frerk; M Goldmann; M Bulduk; Axel R Zander
Efficient depletion of alloreactive donor T lymphocytes based on expression of two activation-induced antigens (CD25 and CD69).
British journal of haematology 2000;109(3):644-51.
2000: Boris Fehse; A Richters; K Putimtseva-Scharf; Hannes Klump; Zhixiong Li; Wolfram Ostertag; Axel R Zander; Christopher Baum
CD34 splice variant: an attractive marker for selection of gene-modified cells.
Molecular therapy : the journal of the American Society of Gene Therapy 2000;1(5 Pt 1):448-56.
2000: Klaus Kühlcke; Francis Ayuk; Z Li; Carsten Lindemann; Andrea Schilz; UM Schade; Axel A Fauser; Axel R Zander; Hans-Georg Eckert; Boris Fehse
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S96-8.
2000: Boris Fehse; M Goldmann; O Frerk; M Bulduk; Axel R Zander
Depletion of alloreactive donor T cells using immunomagnetic cell selection.
Bone marrow transplantation 2000;25 Suppl 2():S39-42.
2000: Matthias Dürken; C Herrnring; Barbara Finckh; S Nagel; Peter Nielsen; R Fischer; Howard M Berger; Ralf M W Moison; Uwe Pichlmeier; B Kohlschütter; Axel R Zander; Alfried Kohlschuetter
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation.
Free radical biology & medicine 2000;28(6):887-94.
2000: J Clausen; Marcus Stockschläder; Natalja Fehse; HT Hassan; C Gabl; Axel R Zander
Blood-derived macrophage layers in the presence of hydrocortisone support myeloid progenitors in long-term cultures of CD34+ cord blood and bone marrow cells.
Annals of hematology 2000;79(2):59-65.
2000: Nicolaus Kröger; William H Krüger; Helmut Renges; W Zeller; C Rauhöft; C Löliger; Axel R Zander
Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: influence on CD34+ cell yield, subpopulation, and breast cancer cell contamination.
Journal of hematotherapy & stem cell research 2000;9(1):111-7.
2000: Nicolaus Kröger; C Rauhöft; W Zeller; Helmut Renges; HT Hassan; William H Krüger; Gunter Schuch; G Wacker-Backhaus; H Colberg; Rolf Kuse; Kai Gutensohn; C Löliger; Axel R Zander
Efficacy of further attempts to mobilize CD34+ peripheral stem cells with alternative procedures after primary failure.
Acta haematologica 2000;102(3):144-7.
1999: W Zeller; Nicolaus Kröger; J Berger; William Krueger; Judith Dierlamm; Marcus Stockschläder; Kai Gutensohn; Dieter K Hossfeld; Axel R Zander
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
Journal of hematotherapy & stem cell research 1999;8(5):539-46.
1999: Matthias Dürken; Martin Horstmann; P Bieling; Rudolf Erttmann; Hartmut Kabisch; C Löliger; E Marion Schneider; Hans-Henning Hellwege; William H Krüger; Nicolaus Kröger; Axel R Zander; Gritta Janka
Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors: a single-centre experience of 12 patients.
British journal of haematology 1999;106(4):1052-8.
1999: D Skiera; W Zeller; Axel R Zander
Graft engineering of G-CSF-mobilized allogeneic leukapheresis products by counterflow centrifugal elutriation after CD34 column adsorption.
Journal of hematotherapy 1999;8(3):299-304.
1999: Axel R Zander; Tatjana Zabelina; Nicolaus Kröger; Helmut Renges; William H Krüger; C Löliger; Matthias Dürken; Marcus Stockschläder; Maike de Wit; G Wacker-Backhaus; Stefan S Bielack; N Jaburg; Bettina Rüssmann; Rudolf Erttmann; Hartmut Kabisch
Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Bone marrow transplantation 1999;23(9):889-93.
1999: William H Krüger; Florian Tögel; Nicolaus Kröger; S Rössing; F Gieseking; Kai Gutensohn; C Lindner; Fritz Jänicke; Axel R Zander
Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer.
Medical oncology (Northwood, London, England) 1999;16(1):17-22.
1999: William H Krüger; Bettina Rüssmann; Nicolaus Kröger; C Salomon; N Ekopf; H A Elsner; Paul-Michael Kaulfers; D Mack; N Fuchs; Matthias Dürken; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Bone marrow transplantation 1999;23(6):589-97.
1999: HT Hassan; T Hinz; N Kroger; W Zeller; Axel R Zander
Factors influencing platelet recovery after autologous transplantation of G-CSF-mobilized peripheral blood stem/progenitor cells following myeloablative therapy in 50 heavily pretreated lymphoma patients.
Clinical and laboratory haematology 1999;21(1):21-7.
1999: William H Krüger; Florian Tögel; S Rössing; Nicolaus Kröger; Axel R Zander
Improvement of breast cancer cell detection by immunomagnetic enrichment.
Cytotherapy 1999;1(2):135-9.
1999: Nicolaus Kröger; W Zeller; HT Hassan; William H Krüger; Kai Gutensohn; C Löliger; Axel R Zander
Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2 x 5 microg/kg) compared to a single dose (1 x 10 microg/kg).
Bone marrow transplantation 1999;23(2):125-9.
1998: William H Krüger; Nicolaus Kröger; Bettina Rüssmann; Helmut Renges; Hartmut Kabisch; Axel R Zander
Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B.
Bone marrow transplantation 1998;22 Suppl 4():S10-3.
1998: Nicolaus Kröger; William H Krüger; G Wacker-Backhaus; Susanna Hegewisch-Becker; Marcus Stockschläder; N Fuchs; Bettina Rüssmann; Helmut Renges; Matthias Dürken; Stefan S Bielack; Maike de Wit; Gunter Schuch; H Bartels; Dietrich Braumann; Rolf Kuse; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Intensified conditioning regimen in bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bone marrow transplantation 1998;22(11):1029-33.
1998: Nicolaus Kröger; W Zeller; Natalja Fehse; HT Hassan; William H Krüger; Kai Gutensohn; C Lölliger; Axel R Zander
Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patients.
British journal of haematology 1998;102(4):1101-6.
1998: Matthias Dürken; E Marion Schneider; R Blütters-Sawatzki; B Stollmann-Gibbels; G Nessler; R Bretz; Dieter Körholz; E N Probst; H Holsten-Griffin; E Harps; Axel R Zander; Gritta Janka
[Treatment of hemophagocytic lymphohistiocytosis, HLH, with bone marrow transplantation].
Klinische Pädiatrie 1998;210(4):180-4.
1998: Boris Fehse; UM Schade; Zhixiong Li; A Uhde; S Koch; B Goller; R Rüger; Natalja Fehse; Marcus Stockschläder; Axel R Zander
Highly-efficient gene transfer with retroviral vectors into human T lymphocytes on fibronectin.
British journal of haematology 1998;102(2):566-74.
1998: Nicolaus Kröger; W Zeller; HT Hassan; William H Krüger; Helmut Renges; K Hummel; Kai Gutensohn; C Lölliger; Axel R Zander
Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF alone.
Annals of hematology 1998;76(6):257-62.
1998: Nicolaus Kröger; MM Hoffknecht; Mathias Hänel; William H Krüger; W Zeller; Marcus Stockschläder; Maike de Wit; HJ Weh; Hartmut Kabisch; Rudolf Erttmann; Axel R Zander
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy.
Bone marrow transplantation 1998;21(12):1171-5.
1998: Boris Fehse; Zhixiong Li; UM Schade; A Uhde; Axel R Zander
Impact of a new generation of gene transfer markers on gene therapy.
Gene therapy 1998;5(4):429-30.
1998: William H Krüger; M Gruber; S Hennings; Natalja Fehse; Boris Fehse; Kai Gutensohn; Nicolaus Kröger; Axel R Zander
Purging and haemopoietic progenitor cell selection by CD34+ cell separation.
Bone marrow transplantation 1998;21(7):665-71.
1998: Nicolaus Kröger; W Zeller; HT Hassan; W Krüger; C Löliger; Axel R Zander
Schedule-dependency of granulocyte colony-stimulating factor in peripheral blood progenitor cell mobilization in breast cancer patients.
Blood 1998;91(5):1828.
1998: Z X Li; UM Schade; Boris Fehse; Marcus Stockschläder; A Uhde; S Koch; B Goller; R Rüger; Natalja Fehse; Axel R Zander
High-efficiency retroviral vector-mediated gene transfer into human T lymphocytes.
Advances in experimental medicine and biology 1998;451():375-8.
1998: Nicolaus Kröger; MM Hoffknecht; P Dreger; William H Krüger; W Zeller; Andreas Krüll; Marcus Stockschläder; S Bittner; HJ Weh; Axel R Zander
Long-term disease-free survival of patients with advanced mantle-cell lymphoma following high-dose chemotherapy.
Bone marrow transplantation 1998;21(1):55-7.
1998: Jan Grimm; W Zeller; Axel R Zander
Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantations as a marker for GVHD.
Bone marrow transplantation 1998;21(1):29-32.
1998: Nicolaus Kröger; W Zeller; HT Hassan; Judith Dierlamm; Axel R Zander
Difference between expression of adhesion molecules on CD34+ cells from bone marrow and G-CSF-stimulated peripheral blood.
Stem cells (Dayton, Ohio) 1998;16(1):49-53.
1997: Axel R Zander; C Berger; Nicolaus Kröger; M Stockshläder; William H Krüger; Martin Horstmann; Jan Grimm; W Zeller; Hartmut Kabisch; Rudolf Erttmann; P Schönrock; Rolf Kuse; Dietrich Braumann; Hans-Jochen Illiger; Walter Fiedler; M de Witt; K D Hossfeld; HJ Weh
High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2671-5.
1997: Boris Fehse; A Uhde; Natalja Fehse; Hans-Georg Eckert; J Clausen; R Rüger; S Koch; Wolfram Ostertag; Axel R Zander; Marcus Stockschläder
Selective immunoaffinity-based enrichment of CD34+ cells transduced with retroviral vectors containing an intracytoplasmatically truncated version of the human low-affinity nerve growth factor receptor (deltaLNGFR) gene.
Human gene therapy 1997;8(15):1815-24.
1997: HT Hassan; C Krog; Marcus Stockschläder; W Zeller; William H Krüger; Rudolf Erttmann; Axel R Zander
Factors influencing haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis. A single-centre experience.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(4):299-306.
1997: William H Krüger; Marcus Stockschläder; Ingo Sobottka; R Betker; Maike de Wit; Nicolaus Kröger; Jan Grimm; M Arland; Walter Fiedler; Rudolf Erttmann; Axel R Zander
Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.
Leukemia & lymphoma 1997;24(5-6):491-9.
1997: HT Hassan; N J Drize; Axel R Zander; R Neth
Fibronectin increases both non-adherent cells and CFU-GM while collagen increases adherent cells in human normal long-term bone marrow cultures.
Haematologia 1997;28(2):77-84.
1997: Guenther Koehne; W Zeller; M Stockschlaeder; Axel R Zander
Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 1997;19(2):149-56.
1997: Matthias Dürken; Peter Nielsen; S Knobel; Barbara Finckh; C Herrnring; B Dresow; B Kohlschütter; Marcus Stockschläder; William H Krüger; Alfried Kohlschuetter; Axel R Zander
Nontransferrin-bound iron in serum of patients receiving bone marrow transplants.
Free radical biology & medicine 1997;22(7):1159-63.
1997: HT Hassan; C Krog; Marcus Stockschläder; B Schleimer; W Zeller; William H Krüger; Rudolf Erttmann; Axel R Zander
Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Anticancer research 1997;17(1B):589-99.
1996: HT Hassan; Marcus Stockschläder; B Schleimer; W Krüger; Axel R Zander
Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
Transplant immunology 1996;4(4):319-23.
1996: Axel R Zander; W Krüger; Nicolaus Kröger; L Damon; M Königmann; W E Berdel; F Gieseking; K Schäfer-Eckart; V Möbus; N Frickhofen; Hannes Wandt; Hans-Jochen Illiger; Bernd Metzner; K Kolbe; B Wörmann; L Trümper; C Huber; Dieter K Hossfeld; H Maass; W Jonat
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Bone marrow transplantation 1996;18 Suppl 1():S24-5.
1996: W H Krüger; Marcus Stockschläder; S Hennings; M Aschenbrenner; M Gruber; Kai Gutensohn; C Löliger; F Gieseking; W Jonat; Axel R Zander
Detection of cancer cells in peripheral blood stem cells of women with breast cancer by RT-PCR and cell culture.
Bone marrow transplantation 1996;18 Suppl 1():S18-20.
1996: HT Hassan; Axel R Zander
Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
Journal of hematotherapy 1996;5(4):407-14.
1996: HT Hassan; W Zeller; Marcus Stockschläder; W Krüger; MM Hoffknecht; Axel R Zander
Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
Stem cells (Dayton, Ohio) 1996;14(4):419-29.
1996: W Zeller; Kai Gutensohn; Marcus Stockschläder; Judith Dierlamm; Nicolaus Kröger; Guenther Koehne; K Hummel; Hartmut Kabisch; HJ Weh; P Kühnl; D K Hossfeld; Axel R Zander
Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.
Bone marrow transplantation 1996;17(5):709-13.
1996: HT Hassan; B Biermann; Axel R Zander
Maintenance and expansion of erythropoiesis in human long-term bone marrow cultures in presence of erythropoietin plus stem cell factor and interleukin-3 or interleukin-11.
European cytokine network 1996;7(2):129-36.
1996: HT Hassan; M Stockschläder; W Krüger; H Hoffknecht; Axel R Zander
G-CSF administration following peripheral blood selected CD34-positive cells autologous transplantation accelerates haematological recovery after myeloablative therapy.
British journal of haematology 1996;92(4):1027-9.
1996: W Krüger; C Krzizanowski; M Holweg; Marcus Stockschläder; Nicolaus Kröger; R Jung; K Mross; W Jonat; Axel R Zander
Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients.
Journal of cancer research and clinical oncology 1996;122(11):679-86.
1995: W Zeller; I Hesse; Matthias Dürken; M Stockschläder; W Krüger; S O Peters; T A Walter; C Greenshaw; H Kabisch; Axel R Zander
Increasing the yield of harvested bone marrow cells by raising room temperature during marrow collection.
Experimental hematology 1995;23(14):1527-9.
1995: Jan Grimm; W Zeller; Axel R Zander
Separation and characterization of mobilized and unmobilized peripheral blood progenitor cells by counterflow centrifugal elutriation.
Experimental hematology 1995;23(6):535-44.
1995: S O Peters; Marcus Stockschläder; Susanna Hegewisch-Becker; W Krüger; H J Weh; Dieter K Hossfeld; Axel R Zander
Infusion of tumor-contaminated bone marrow for autologous rescue after high-dose therapy leading to long-term remission in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Bone marrow transplantation 1995;15(5):783-4.
1995: W H Krüger; C Berger; K B Mross; P Bewermeier; Uwe Pichlmeier; Marcus Stockschläder; B Schleimer; Axel R Zander
Inhibition of CFU-C growth by VP-16 containing plasma samples obtained from patients after conditioning therapy for bone marrow transplantation.
Bone marrow transplantation 1995;15(1):9-15.
1993: S O Peters; Marcus Stockschläder; W Zeller; K Mross; Matthias Dürken; W Krüger; Axel R Zander
Monoclonal gammopathy of unknown significance in a bone marrow donor.
Annals of hematology 1993;66(2):93-5.
1993: P Kapaun; Hartmut Kabisch; K R Held; T A Walter; S Hegewisch; Axel R Zander
Atypical chronic myelogenous leukemia in a patient with trisomy 8 mosaicism syndrome.
Annals of hematology 1993;66(1):57-8.